Follicullar Development and Embryo Recovery Following 3 versus 8 FSH Injections in Heifers

Ovarian follicular dynamics and embryo yield were studied during 2 different FSH regimens for superovulation of cattle. Twenty heifers were given intramuscular injections of FSH (total of 35 mg NIH) either once daily for 3 days (Group 3×1) or twice daily for 4 days (Group 4×2). At 72 h after the first FSH injection, each animal was injected with 0.75 mg cloprostenol. Inseminations were performed at 12 h and 24 h after the onset of heat. Transrectal ultrasonography was performed on the day of the first FSH injection, the day of cloprostenol injection, the day of insemination and finally on the day of embryo recovery (day 6 or 7 after heat). The numbers of small (2–4 mm), medium (5–9 mm) and large (>10 mm) size follicles were recorded. The total number of corpora lutea, eggs and transferable embryos were recorded on the day of embryo recovery. No differences were found between the 2 groups in either of the parameters studied (p>0.05). It can be concluded that treatment with this FSH preparation once daily for 3 days gives a folliculogenic and superovulatory response similar to a treatment regimen where it is given twice daily for 4 days.     

波尔山羊胚胎移植影响因素的分析

波尔山羊胚胎移植效果受诸多因素的影响，供体状况、药物、季节等因素使供体超排效果产生较大的差异，而受体状况、胚胎质量等对受体的妊娠率产生较大的影响，这些因素阻碍了波尔山羊胚胎移植的产业化应用。本文对以上影响波尔山羊胚胎移植效果的因素进行了分析，以期为提高胚胎移植效率提供依据，从而促进波尔山羊胚胎移植产业化进程。     

Induction of oestrus by administering Inhibin antiserum along with equine chorionic gonadotropin in anoestrous bitches

As dogs experience oestrus only once or twice a year, it is necessary to establish an effective method of oestrous induction for efficient breeding. In the present study, we evaluated inhibin antiserum (IAS) on oestrous induction in anoestrous females. Bitches were administered 0.5 ml/kg IAS or a mixture of 50 IU/kg equine chorionic gonadotropin (eCG) and 0.5 ml/kg IAS and 500 IU human chorionic gonadotropin (hCG) administered 7 days after the mixture injection. As a control, bitches received 50 IU/kg eCG, with 500 IU hCG administered 7 days after eCG injection. Blood-tinged vaginal discharge, vulvar swelling, plasma progesterone concentrations and ovarian follicular development were assessed from day 0 to day 14. IAS alone injection did not induce oestrus in bitches at the anoestrous stage. Conversely, vulvar swelling, blood-tinged vaginal discharge and an estimated luteinizing hormone (LH) surge appeared on days 3–7, days 3–6 and days 7–9 after the IAS+eCG mixture injection, respectively, in all five bitches at the anoestrous stage. The average number of developing and ovulated follicles in bitches administered IAS+eCG was 8.8 and 9.6 respectively. A single eCG injection followed by hCG induced oestrous signs, with an average of 8.3 developing follicles and 4.5 ovulated follicles. This study revealed that IAS alone did not induce oestrus, but when IAS was used in combination with eCG, it induced oestrus and promoted a considerable number of ovulations in anoestrous dogs.     

家兔超数排卵和胚胎移植妊娠率的影响因素分析

应用FSH和HCG相结合的不同方法 (递减量与恒量法),对不同兔龄和是否经产的中国家兔进行了超数排卵处理。其中,递减量法超排处理:每间隔12 h依次肌肉注射15、15、10、10、5及5 U/只共60 U的FSH,6次之后间隔12 h,经耳缘静脉注射HCG 100 U/只,合笼;恒量法超排处理:每间隔12 h肌肉注射10 U/只共60 U的FSH,6次之后间隔12 h,经耳缘静脉注射HCG 100 U/只,合笼。17 h后,取卵经显微注射后移植到排卵点分布不同的家兔输卵管中,比较分析了超数排卵及胚胎移植妊娠率的影响因素,旨在优化兔超数排卵和胚胎移植方法。结果显示,①总量为60 U的FSH递减量肌肉注射法超排效果略优于恒量法(688枚、671枚),但差异不显著(P>0.05);②9～11月龄的母兔超排效果明显优于6～8月龄的母兔(794枚、565枚),差异显著(P<0.05);③经产母兔的超排效果明显优于未经产的母兔(887枚、472枚),差异显著(P<0.05);④经显微注射重组DNA的胚胎移植受体时,两侧卵巢均有排卵点的胚胎移植受体妊娠率明显高于一侧卵巢有排卵点和两侧卵巢均无排卵点的受体(81.25%、38.46%、37.50%),差异显著(P<0.05)。试验证明,通过肌肉注射递减总量为60 U的FSH对9～11月龄经产母兔的超排效果最佳,且两侧卵巢均有排卵点的受体胚胎移植妊娠率最高,为胚胎研究工作者提供了一定的参考依据。     

影响波尔山羊超排效果的因素

对204只(次)波尔山羊采用C IDR+FSH+PG法超数排卵(以下简称超排),发情配种后第6天采用手术法从子宫角采胚,采胚成功率为92.16%(188/204),头均获胚(16.68±7.89)枚,其中头均获可用胚(14.11±8.37)枚,可用胚率84.66%(2 654/3 135)。对不同国家产FSH、不同剂量FSH、注射LRH+P4、不同季节、重复超排、左右侧卵巢等因素对波尔山羊超排效果的影响进行了研究。结果表明,以日本和国产(动物所)FSH超排效果为佳,头均获可用胚分别为(15.66±8.26)枚(n=89)和(15.39±6.91)枚(n=23);日本产FSH 14~16 mL组效果最佳,头均获可用胚(19.63±8.96)枚(n=19);注射LRH+P4组头均获可用胚(16.04±8.84)枚(n=80),极显著高于对照组(12.16±7.68)枚(n=62);春季、秋季、冬季超排头均获可用胚分别为(10.86±5.10)枚(n=7)、(11.30±8.29)枚(n=23)、(11.00±6.17)枚(n=10),差异不显著;重复超排(间隔12月)第1次头均获可用胚(15.08±5.12)枚(n=26),第2次头均获可且胚(16.92±8.32)枚(n=26)。     

波尔山羊FSHR5’端序列的SNP多态性及超排效果分析

为探索波尔山羊超排个体排卵数差异与个体遗传特性的相关性,对波尔山羊的FSHR基因(950 bp),分成四段分别设计引物进行PCR-SSCP多态性分析,结果发现一个SNP位点,导致5-’1出现两种基因型。序列分析显示该突变位点位于转录起始点上游-739bp处,属于远端转录启动调控区。统计分析表明AA型个体的平均排卵数与AB型个体的平均排卵数差异极显著(P<0.01),平均胚胎可利用率差异显著(P<0.05),这说明个体的超排潜力可能与其本身的FSHR基因的遗传特性有关。     

秦川牛超数排卵效果的研究

本研究共超排秦川牛31头次，有效超排20头次，有效率为64.5％。头均获胚总数6.45枚，可用胚4.20枚。激素用量为300 mg/头时，头均获胚总数和头均可用胚数显著高于260和340 mg组（P<0.05）。冬春季的头均获胚总数（8.56）和头均可用胚数（6.00）显著高于夏秋季（4.73、2.73）（P<0.05）。对供体牛连续超排处理3次，间隔70 d，对超排效果无显著影响。     

激素对波尔山羊超排效果影响的研究

以波尔山羊为研究对象,研究激素对供体超排效果的影响。结果表明,FSH剂量对供体超排效果有显著影响,随FSH剂量的增加,育成羊的黄体数极显著增多,经产羊的可用胚数显著增加;国产和进口激素对超排效果影响不显著(P>0.05),国产激素完全可以代替进口激素用于波尔山羊的超排;供体发情配种时用LHRH-A3促排的效果比LH、hCG好。     

Exogenous eFSH, follicle coasting, and hCG as a novel superovulation regimen in mares

The objective of this study was to evaluate various equine follicle-stimulating hormone (eFSH) treatment protocols and the effect of “follicle coasting” on ovulation and embryo recovery rates in mares. Cycling mares (n = 40) were randomly assigned to one of four groups 7 days after ovulation: (1) 12.5 mg eFSH twice daily until follicles were 35 mm or larger; (2) 12.5 mg eFSH twice daily until follicles were 32 mm or larger; (3) 12.5 mg eFSH twice daily for 3.5 days followed by 12.5 mg eFSH enriched with luteinizing hormone (LH) twice daily until follicles were 35 mm or larger; and (4) 25 mg eFSH once daily until follicles were 32 mm or larger. Mares in groups 1 and 3 were injected with human chorionic gonadotropin (hCG) (2500 IU intravenously) at the end of eFSH treatment, whereas mares in groups 2 and 4 were given hCG approximately 42 and 54 hours, respectively, after the last eFSH treatment (“follicle coasting”). Nonsurgical embryo collection was performed 6.5 to 7.5 days after ovulation. Each mare experienced a nontreated estrous cycle before being reassigned to a second treatment. Ovulation rates for mares in treatment groups 1 to 4 were 3.3 ± 0.4, 4.1 ± 0.4, 3.5 ± 0.4, and 2.8 ± 0.4 (mean ± SEM; P < .05), respectively. One or more embryos were recovered from more than 80% of mares in each treatment group, and embryo recovery rate per flush was similar among treatment groups (1.9 ± 0.3, 2.6 ± 0.3, 1.9 ± 0.3 and 1.9 ± 0.3, respectively; P > .05). The overall embryo recovery rate was 2.1 ± 1.5 embryos per flush. In summary, ovulation rate was higher for mares treated with eFSH (3.4 ± 0.4) compared with non-treated controls (1.1 ± 0.2). Ovulation rate in mares in which hCG was delayed (follicle coasting) was higher (P < .05) when treatments were given twice per day versus once per day. Administration of equine luteinizing hormone (eLH) in conjunction with eFSH did not have an advantage over mares treated only with eFSH.